Adrenocorticotropic hormone ( DrugBank: Adrenocorticotropic hormone )

3 diseases

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02446886 (ClinicalTrials.gov)	June 2016	7/5/2015	Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS	Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS	Multiple Sclerosis	Drug: Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)	Weill Medical College of Cornell University	Mallinckrodt	Completed	18 Years	N/A	All	15	Phase 4	United States
2	NCT02290444 (ClinicalTrials.gov)	August 2013	23/10/2014	Effects of Acthar on Recovery From Cognitive Relapses in MS	Effects of Adrenocorticotropic Hormone(ACTHAR Gel) on Recovery From Cognitive Relapses in Multiple S ...	Multiple Sclerosis	Drug: Adrenocorticotropic Hormone	State University of New York at Buffalo	NULL	Completed	18 Years	65 Years	All	64	Phase 3	United States

臨床試験数 : 194 / 薬物数 : 244 - (DrugBank : 89) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 151

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01906372 (ClinicalTrials.gov)	September 2013	5/7/2013	Acthar in Treatment of Refractory Dermatomyositis and Polymyositis	Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic HormoneGel ...	Dermatomyositis;Polymyositis	Drug: Adrenocorticotropic Hormone Gel	Rohit Aggarwal, MD	Mallinckrodt	Completed	18 Years	N/A	All	12	Phase 2	United States

臨床試験数 : 149 / 薬物数 : 202 - (DrugBank : 78) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 169

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02155803 (ClinicalTrials.gov)	February 2015	30/5/2014	ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study	ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study	Sarcoidosis;Hypercalcemia Due to Sarcoidosis	Drug: ACTHAR Gel (adrenocorticotropic hormone)	Albany Medical College	NULL	Not yet recruiting	18 Years	N/A	Both	10	Phase 2/Phase 3	United States